Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00107679 · ClinicalTrials.gov registry record

A Study of Anal Cancer Development in HIV Infected People

A clinical trial of HIV Infections and Anus Neoplasms, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
560
Enrollment target
13
Study locations

NCT00107679 is a study of HIV Infections and Anus Neoplasms that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 560 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (26% higher). The trial reports 13 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00107679, a study of HIV Infections and Anus Neoplasms, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
560 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this study is to compare the development of abnormal cell growth or cancer in the anal region of individuals who are receiving one of two different anti-HIV treatment strategies.

Conditions Studied

HIV Infections Anus Neoplasms

Study Locations (13)

California

  • LA Gay & Lesbian Community Service Ctr., Lamba Med. Group CRS - Los Angeles
  • Castro-Mission Health Ctr. CRS - San Francisco

Colorado

  • Univ. of Colorado Health Science Ctr. CRS - Denver
  • Eastside Family Health Ctr. CRS - Denver

Oregon

  • Kaiser Immune Deficiency Clinic of Portland CRS - Portland
  • Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS - Portland

District of Columbia

  • Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS - Washington D.C.

Florida

  • Univ. of Florida, Div. of Infectious Diseases CRS - Jacksonville

Massachusetts

  • CRI-Boston CRS - Boston

Michigan

  • Henry Ford Hosp. CRS - Detroit

New York

  • Harlem Hospital Ctr./Columbia University CRS (Gordin CTU) - New York

Trial Details

FieldValue
Enrollment Target 560 participants
Start Date 2005-02
Est. Completion 2006-03

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00107679

The ClinicalTrials.gov registry entry for NCT00107679 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (26% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00107679 reports 13 study locations spanning 10 distinct geographic areas - top geographies include California, Colorado, Oregon.

Frequently Asked Questions

What is clinical trial NCT00107679 about?

NCT00107679 is a clinical study titled "A Study of Anal Cancer Development in HIV Infected People". The purpose of this study is to compare the development of abnormal cell growth or cancer in the anal region of individuals who are receiving one of two different anti-HIV treatment strategies.

What is the current status of trial NCT00107679?

This trial is currently completed. The enrollment target is 560 participants. The study started on 2005-02. Estimated completion is 2006-03.

What conditions does trial NCT00107679 study?

This clinical trial studies the following conditions: HIV Infections, Anus Neoplasms.

Who is sponsoring clinical trial NCT00107679?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00107679 being conducted?

This trial has 13 study locations across California, Colorado, District of Columbia, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Anus Neoplasms

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.